Gene · 11167
Papers1,795
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,795
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SPARC family proteins: matricellular modulators of cancer progression and therapeutic resistance. | Cancer Gene Ther | 2026 | 41974927 | PubTator, text mining | PubMed |
| Suppressed brain-derived neurotrophic factor response to 6 min walking exercise in mild cognitive impairment. | Brain Behav Immun | 2026 | 41912101 | PubTator, text mining | PubMed |
| Global molecular landscape of early MASLD progression in human obesity. | Elife | 2026 | 41870035 | PubTator, text mining | PubMed |
| The role of exosomes in ankylosing spondylitis: from biological features and functional cargo to clinical applications. | Front Mol Biosci | 2026 | 41777666 | PubTator, text mining | PubMed |
| Integrated transcriptomics and molecular docking identify hub genes and statin regulators in Helicobacter pylori-associated gastric mucosal pathogenesis. | Front Cell Infect Microbiol | 2026 | 41769350 | PubTator, text mining | PubMed |
| Effect of PKM2 on M. tuberculosis Rv1987-induced macrophage M2 polarization. | Front Cell Infect Microbiol | 2026 | 41769337 | PubTator, text mining | PubMed |
| Multimodal characterization of sustained bioagent release from an epicardial depot for long-term biomaterial incorporation. | Biomaterials | 2026 | 41740294 | PubTator, text mining | PubMed |
| Current insights into circulating biomarkers and their potential for predicting adolescent idiopathic scoliosis progression. | Front Cell Dev Biol | 2026 | 41727319 | PubTator, text mining | PubMed |
| Cross-Platform Transcriptomic Analysis of 40 Human and Rodent Skeletal Muscle Exerkines. | Muscles | 2026 | 41718082 | PubTator, text mining | PubMed |
| Mechanisms of mitral valve development and disease. | Front Cardiovasc Med | 2026 | 41717582 | PubTator, text mining | PubMed |
| FSTL1 promotes dendritic cell pyroptosis and immunosuppression in sepsis by inhibiting STING autophagy. | PLoS One | 2026 | 41701691 | PubTator, text mining | PubMed |
| Circulating Activin A and Follistatin-like Proteins in Rheumatoid Arthritis with Interstitial Lung Disease: A Cross-Sectional Comparative Study. | Diagnostics (Basel) | 2026 | 41681720 | PubTator, text mining | PubMed |
| Signalling pathways regulated by FSTL1 in inflammation and potential therapeutic applications (Review). | Int J Mol Med | 2026 | 41645756 | PubTator, text mining | PubMed |
| Ischemic preconditioning modulates iron metabolism, acute inflammatory and neurotrophic responses to anaerobic exercise in untrained individuals: a randomized controlled trial. | Sci Rep | 2026 | 41639166 | PubTator, text mining | PubMed |
| Serum FSTL-1 and AI-assessed muscle parameters in cancer-related malnutrition. | Nutrition | 2026 | 41637915 | PubTator, text mining | PubMed |
| FSTL1 contribute to aggressive clinical behavior in DLBCL may by activating the DIP2A/ICAM-1-mediated adhesion mechanism. | Biomed Pharmacother | 2026 | 41616470 | PubTator, text mining | PubMed |
| Injured epithelial cell states impact kidney allograft survival after T-cell-mediated rejection. | Nat Commun | 2026 | 41605921 | PubTator, text mining | PubMed |
| Enarodustat suppresses thymic stromal lymphopoietin expression via hypoxia-inducible factor-mediated c-Jun N-terminal kinases dephosphorylation. | PLoS One | 2026 | 41576104 | PubTator, text mining | PubMed |
| Extracellular Vesicle-Derived microRNAs as Fluid Biomarkers in Neurodegenerative Diseases: A Systematic Review. | J Neurochem | 2026 | 41572495 | PubTator, text mining | PubMed |
| GLP-1 Targeting Agents Impair Chemoimmunotherapy Effectiveness in Triple-Negative Breast Cancer. | Res Sq | 2026 | 41542041 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11167/papers?page=2